Related Experiment Video
Updated: Dec 13, 2025

Yeast As a Chassis for Developing Functional Assays to Study Human P53
Published on: August 4, 2019
SPARC-p53: The double agents of cancer
Denise Camacho1, Joana P Jesus1, António M Palma1
1Champalimaud Centre for the Unknown, Lisbon, Portugal.
Abstract:
Cancer is a complex disease with high incidence and mortality rates. The important role played by the tumor microenvironment in regulating oncogenesis, tumor growth, and metastasis is by now well accepted in the scientific community. SPARC is known to participate in tumor-stromal interactions and impact cancer growth in ambiguous ways, which either enhance or suppress cancer aggressiveness, in a context-dependent manner. p53 transcription factor, a well-established tumor suppressor, has been reported to promote tumor growth in certain situations, such as hypoxia, thus displaying a duality in its action. Although both proteins are being tested in clinical trials, the synergistic relation between them is yet to be explored in clinical practice. In this review, we address the controversial roles of SPARC and p53 as double agents in cancer, briefly summarizing the interaction found between these two molecules and its importance in cancer.
Insights
Secreted protein acidic and rich in cysteine (SPARC) and p53 exhibit dual roles in cancer progression. This review explores their complex interactions within the tumor microenvironment, highlighting potential therapeutic implications.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- The tumor microenvironment significantly influences cancer development and spread.
- SPARC (secreted protein acidic and rich in cysteine) has context-dependent roles in cancer, affecting tumor-stromal interactions.
- The p53 transcription factor, a known tumor suppressor, can paradoxically promote tumor growth under specific conditions like hypoxia.
Purpose of the Study:
- To review the dualistic roles of SPARC and p53 in cancer.
- To summarize the interaction between SPARC and p53.
- To discuss the clinical relevance of their synergistic relationship.
Main Methods:
- Literature review of existing studies on SPARC and p53 in cancer.
- Analysis of tumor microenvironment interactions.
- Exploration of context-dependent protein functions.
Main Results:
- SPARC and p53 display ambiguous functions, acting as 'double agents' in cancer.
- Their interaction influences cancer aggressiveness and progression.
- The interplay between SPARC and p53 is crucial in the tumor microenvironment.
Conclusions:
- Understanding the complex roles of SPARC and p53 is vital for cancer therapy.
- Further research into their synergistic relationship may reveal new clinical strategies.
- Targeting these proteins could offer novel therapeutic avenues.
Related Concept Videos
Abnormal Proliferation
DNA Damage Can Stall the Cell Cycle
DNA Damage can Stall the Cell Cycle
Negative Regulator Molecules
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

